Canary Speech Launches Canary Ambient

Canary Speech, a provider of vocal biomarker technology, has launched Canary Ambient which offers real-time voice analysis during clinical conversations, enabling actionable insights into patient-clinician dialogues, tracking speech patterns, and real-time assessments of cognitive and behavioral health conditions.

With its advanced voice processing capabilities, Canary Ambient helps organizations identify potential at-risk individuals who would benefit from further evaluation.

Key Features of Canary Ambient include the following:

• Real-time streaming audio processing, which captures live audio from clinical environments and contact centers, allowing for vocal biomarker results to be calculated and made available in real time, during the conversation.
• Advanced diarization to separate voices into distinct channels, offering clear and accurate recommendations for both parties involved.
• Role identification which differentiates between participants.
• Vocal biomarker analysis for signs of health conditions such as anxiety, depression, and Alzheimer's.
• Customizable analysis on one or both participants, enabling targeted insights for different use cases.
• Seamless integration with existing healthcare systems, AI-powered tools, and contact center platforms.
• Secure data handling that complies with privacy and security standards like HIPAA, HITRUST, and relevant regulations for contact centers.

"We are thrilled to offer Canary Ambient, which will allow many more organizations to integrate vocal biomarker analysis into existing workflows, improving patient care and customer service," said Henry O'Connell, CEO of Canary Speech, in a statement.

"Canary Speech's clinical ambient listening allows for seamless vocal biomarker analysis that captures the natural interaction between a clinician and their patient with no additional prompting required," said Nate Blaylock, chief technology officer of Canary Speech, in a statement. "This technology supports the clinician in identifying patients who may benefit from additional screening."